Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 3
1(33.3%)
3Total
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05156736Recruiting

Pakistan Study of Premature Coronary Atherosclerosis in Young Adults

Role: lead

NCT05591872Phase 3Unknown

Low Dose Heparin Factorial Trial

Role: lead

NCT04380883Not ApplicableCompleted

Combination of InnoSEAL Plus TR Band Compared to TR Band Alone

Role: lead

NCT04389814Unknown

New Time Clock for ST-elevation MI Based on Biochemical Myocardial Infarction Onset Time

Role: lead

NCT04389190Not ApplicableUnknown

Radiation Dose Reduction Using Advanced Fluoroscopy Options in Coronary Cath Lab

Role: lead

All 5 trials loaded